Abstract P169 Table 1

FTD™ Urethritis Plus (7-Plex) detection kit

CTNG
Sample type (n)Females (287)Males (98)MSM Urine
(56)
MSM Rectal
(67)
MSM Pharynx
(71)
Females
(291)
Males
(98)
MSM Urine
(57)
MSM Rectal
(67)
MSM Pharynx
(72)
Sensitivity% (95% CIa)100 (85.7–100b)100 (83.2–100b)66.7 (9.4–99.2)21.9 (14.7–94.7)50.0 (1.3–98.7)80.0 (28.4–99.5)83.3 (35.9–99.6)50.0 (18.7–81.3)78.9 (54.4–93.9)64.7 (38.3–85.8)
Specificity% (95% CIa)99.6 (97.8–100.0)97.4 (90.9–99.7)98.1 (89.9–100)96.8 (88.8–99.6)100 (94.4–100b)99.6 (98.0–100.0)100 (96.1–100b)100 (92.3–100b)83.3 (69.8–92.5)96.4 (87.5–99.6)
PPV (97.5% CIa)96.0 (79.6–99.9)91.3 (71.9–98.9)66.7 (9.4–99.2)21.9 (14.8–94.7)100 (2.5–100b)80 (28.4–99.5)100 (47.8–100b)100 (47.8–100b)65.2 (42.7–83.6)84.6 (54.6–98.1)
NPV (95% CIa)100 (98.6–100b)100 (95.2–100b)98.1 (89.9–100)96.8 (88.8–99.6)97.2 (90.2–99.7)99.6 (98.0–100.0)98.9 (94.1–100)90.2 (78.6–96.7)90.9 (78.3–97.5)89.8 (79.2–96.2)
  • a Binomial Exact

  • b one sided, 97.5% Confidence Interval